Angiotensinogen, angiotensine converting enzyme and plasminogen activator inhibitor-1 gene polymorphism in chronic allograft dysfunction

Molecular Biology Reports

Volumn 36, Issue 5, 2009, Pages 909-915

  Azarpira, Negar ^a   Bagheri, M ^a   Raisjalali, Gh A ^b   Aghdaie, M H ^a   Behzadi, S ^b   Salahi, H ^b   Rahsaz, M ^a   Darai, M ^a   Ashraf, M J ^a   Geramizadeh, B ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Angiotensin converting enzyme; Angiotensinogen; Chronic allograft dysfunction; Plasminogen activator inhibitor 1; Polymorphism

Indexed keywords

ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; ARTICLE; DNA POLYMORPHISM; FEMALE; GENETIC RISK; GENOTYPE; GRAFT DYSFUNCTION; GRAFT RECIPIENT; HUMAN; KIDNEY ALLOGRAFT; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; ALLELES; ANGIOTENSINOGEN; CHRONIC DISEASE; DEMOGRAPHY; FEMALE; GENOTYPE; GRAFT REJECTION; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; PEPTIDYL-DIPEPTIDASE A; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 63949086743     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-008-9262-z     Document Type: Article

References (41)

1. LC Paul 1999 Chronic allograft nephropathy: an update Kidney Int 56 783 793
2. RB Colvin 2003 Chronic allograft nephropathy N Engl J Med 349 2288 2290
3. BJ Nankivell RJ Borrows CL Fung PJ O'Connell RD Allen JR Chapman 2003 The natural history of chronic allograft nephropathy N Engl J Med 349 2326 2333
4. BL Kasiske RS Kalil HS Lee KV Rao 1991 Histopathological findings associated with a chronic, progressive decline in renal allograft function Kidney Int 40 514 524
5. NR Krieger BN Becker DM Heisey BJ Voss AM D'Alessandro YT Becker JS Odorico M Kalayoglu JD Pirsch HW Sollinger SJ Knechtle 2003 Chronic allograft nephropathy uniformly affects recipients of CANaveric, nonidentical living-related and living-unrelated grafts Transplantation 75 1677 1682
6. N Vadivel SG Tullius A Chandraker 2007 Chronic allograft nephropathy Semin Nephrol 27 4 414 429
7. F Cambien F Alhenc-Gelas B Herbeth JL Andre R Rakotovao MF Gonzales J Allegrini C Bloch 1988 Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy study Am J Hum Genet 43 774 780
8. H Yoshida T Mitarai T Kawamura T Kitajima Y Miyazaki R Nagasawa Y Kawaguchi H Kubo I Ichikawa O Sakai 1995 Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy J Clin Invest 96 5 2162 2169
9. K Baboolal D Ravine J Daniels N Williams P Holmans GA Coles JD Williams 1997 Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease Kidney Int 52 3 607 613
10. J Kabat-Koperska M Baskiewicz-Masiuk K Safranow E Golembiewska E Paczkowska A Miklaszewicz K Kedzierska S Giedrys-Kalemba B Machalinski K Ciechanowski 2005 The influence of angiotensin-converting enzyme gene of donor and recipient on the function of transplanted kidney Transplant Proc 37 2 755 759
11. A Akcay S Sezer FN Ozdemir Z Arat FB Atac H Verdi T Colak M Haberal 2004 Association of the genetic polymorphisms of the renin-angiotensin system and endothelial nitric oxide synthase with chronic renal transplant dysfunction Transplantation 78 6 892 898
12. T Slowinski P Diehr P Kleemann L Fritsche L Renders K Budde IA Hauser HH Neumayer B Hocher 2004 No association between renin-angiotensin system gene polymorphisms and early and long-term allograft dysfunction in kidney transplant recipients Nephrol Dial Transplant 19 11 2846 2851
13. X Jeunemaitre F Soubrier YV Kotelevtsev RP Lifton CS Williams A Charru SC Hunt PN Hopkins RR Williams JM Lalouel 1992 Molecular basis of human hypertension: role of angiotensinogen Cell 71 169 180
14. J Gumprecht MJ Zychma W Grzeszczak E Zukowska-Szczechowska 2000 Angiotensin I-converting enzyme gene insertion/deletion and angiotensinogen M235T polymorphisms: risk of chronic renal failure. End-stage renal disease study group Kidney Int 58 513 519
15. K Reis T Arinsoy U Derici S Gonen Z Bicik O Soylemezoglu U Yasavul E Hasanoglu S Sindel 2005 Angiotensinogen and plasminogen activator inhibitor-1 gene polymorphism in relation to chronic allograft dysfunction Clin Transplant 19 1 10 14
16. GV Prasad D Pinnaduwage RK Parkes J Midgley JW Balfe RA Hegele SB Bull EH Cole AG Logan 2003 Angiotensinogen M235T genotype predicts progression in chronic renal allograft dysfunction Transplantation 75 2 209 216
17. S Ye FR Green PY Scrabin V Nicaud L Bara SJ Dawson SE Humphries A Evans G Luc JP Cambou D Arveiler AM Henney F Cambien 1995 The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study Thromb Haemost 74 837 841
18. JP Rerolle A Hertig G Nguyen JD Sraer EP Rondeau 2000 The plasminogen activator inhibitor type 1 as a potential target in renal fibrogenesis Kidney Int 58 1841 1850
19. AB Fogo 2003 Renal fibrosis: not just PAI-1 in the sky J Clin Invest 112 326 328
20. G Zhang KA Kernan SJ Collins X Cai JM López-Guisa JL Degen Y Shvil AA Eddy 2007 Plasmin(ogen) promotes renal interstitial fibrosis by promoting epithelial-to-mesenchymal transition: role of plasmin-activated signals J Am Soc Nephrol 18 3 846 459
21. KM Chow CC Szeto CY Szeto P Poon FM Lai PK Li 2002 Plasminogen activator inhibitor-1 polymorphism is associated with progressive renal dysfunction after acute rejection in renal transplant recipients Transplantation 74 12 1791 1794
22. D Serón F Moreso J Bover E Condom S Gil-Vernet C Cañas X Fulladosa J Torras M Carrera JM Grinyó J Alsina 1997 Early protocol renal allograft biopsies and graft outcome Kidney Int 51 310 316
23. E Lovati A Richard BM Frey FJ Frey P Ferrari 2001 Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease Kidney Int 60 46 54
24. MW Mansfield MH Stickland PJ Grant 1995 Environmental and genetic factors inrelation to elevated circulating levels of plasminogen activator inhibitor-1 in Caucasian patients with non-insulin-dependent diabetes mellitus Thromb Haemost 74 842 847
25. DM Nielsen MG Ehm BS Weir 1998 Detecting marker-disease association by testing for Hardy-Weinberg disequilibrium at a marker locus Am J Hum Genet 63 5 1531 1540
26. J Attia A Thakkinstian C D'Este 2003 Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology J Clin Epidemiol 56 4 297 303
27. R Abdi TB Tran R Zee BM Brenner EL Milford 2001 Angiotensin gene polymorphism as a determinant of posttransplantation renal dysfunction and hypertension Transplantation 72 726 732
28. el-EA Basset P Berthoux S Cecillon C Deprle D Thibaudin JP De Filippis E Alamartin F Berthou 2002 Hypertension after renal transplantation and polymorphism of genes involved in essential hypertension: ACE, AGT, AT1 R and ecNOS Clin Nephrol 57 3 192 200
29. I Inoue T Nakajima CS Williams J Quackenbush R Puryear M Powers T Cheng EH Ludwig AM Sharma A Hata X Jeunemaitre JM Lalouel 1997 A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro J Clin Invest 99 7 1786 1797
30. ME Dickson MB Zimmerman K Rahmouni CD Sigmund 2007 The -20 and -217 promoter variants dominate differential angiotensinogen haplotype regulation in angiotensinogen-expressing cells Hypertension 49 3 631 639
31. G Filler F Yang A Martin J Stolpe HH Neumayer B Hocher 2001 Renin angiotensin system gene polymorphism in pediatric renal transplant recipients Pediatr Transplant 5 3 166 173
32. J Nicod A Richard FJ Frey P Ferrari 2002 Recipient RAS gene variants and renal allograft function Transplantation 73 960 962
33. J Beige G Offermann A Distler AM Sharma 1998 Angiotensin converting-enzyme insertion/deletion genotype and long-term renal allograft survival Nephrol Dial Transplant 131 735 738
34. T Slowinski P Diehr P Kleemann L Fritsche L Renders K Budde IA Hauser HN Neumayer B Hocher 2004 No association between renin-angiotensin system gene polymorphisms and early and long-term allograft dysfunction in kidney transplant recipients Nephrol Dial Transplant 19 11 2846 2851
35. Ayed Kh S Ayed-Jendoubi T Ben Abdallah R Bardi Y Gorgi I Sfar B Dhrif E Abderrahim A Kheder 2006 Polymorphism of the renin-angiotensin-aldosterone system in patients with chronic allograft dysfunction Transpl Immunol 15 4 303 309
36. A Yildiz H Yazici N Cine V Akkaya SM Kayacan MS Sever N Erginel-Unaltuna 2002 The effect of angiotensine converting enzyme gene polymorphism on chronic allograft dysfunction in living donor renal transplant recipients Clin Transplant 16 173 179
37. A Rodríguez-Moreno AI Sánchez-Fructuoso N Ridao-Cano N Calvo J Conesa F Gómez-Gallego C Santiago F Bandrés A Barrientos 2005 Association of the genetic polymorphisms of the renin-angiotensin system with kidney graft long-term outcome: preliminary results Transplant Proc 37 9 3716 3717
38. JD Vasalli AP Sappino D Belin 1991 The plasminogen activator/plasmin system J Clin Invest 88 4 1067 1072
39. H Kimura F Geyjo Y Suzuki S Suzuki R Miyazaki M Arakawa 1998 Polymorphisms of angiotensin-converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy Kidney Int 54 5 1659 1069
40. M Margaglione E Grandone G Vecchione G Cappucci N Giuliani D Colaizzo E Celentano S Panico G Di Minno 1997 Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiontensin converting enzyme (ACE) genes Arterioscler Thromb Vasc Biol 17 10 2082 2087
41. A Hamsten B Wiman U Defaire M Blomback 1985 Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction N Engl J Med 313 25 1557 1563